Unilever PLCULNYSE
Debt/Equity stays at or below 2.2. It has not broken in 11 filed years.
Today it reads 1.76x. Tested against 11 filed years.
Named tests met3 of 30
65.78 USD Market data. Sources for Share price
Close of Nov 11, 2026Market data as of Nov 11, 2026. Ratios computed Nov 11, 2026.
ValueScreener company report
NYSE / Consumer Defensive / Household & Personal Products
Reading
The evidence behind it
Overview
Market dataSEC filingComputed
Four questions, at a glance
Quality
Return on invested capital, after tax
16.6% Computed
From the FY2025 filing
Valuation
Price to earnings
13.40x Computed
FY2025 accounts, priced at 21:00 UTC
Cash generation
Free cash flow yield
5.5% Computed
FY2025 accounts, priced at 21:00 UTC
Strength
Debt to equity
1.76 Computed
From the FY2025 filing
Revenue and net income, as filed
- Market capitalisation
141.70B USD Market data. Sources for Market capitalisation
21:00 UTC- Filed accounts
- FY2025, filed Mar 12, 2026
- Filed years
- 11, FY2015 to FY2025
The business, and the score behind its five axes
The reading, in brief
- Is it cheap
Price to earnings is 13.40x at the close of 2026-11-11 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 10.00x and 15.00x.
Today, against the Consumer Defensive sector (134 companies), 13.40x sits at the 24th percentile; the middle half of that group runs from 13.45x to 31.56x.
- Is it good
Return on invested capital was 16.6% in FY2025, in the band labelled "Above the cost of capital" (12.0% to 20.0%), on lines anchored on Damodaran's cost-of-capital data.
Today, against the Consumer Defensive sector (102 companies), 16.6% sits at the 83rd percentile; the middle half of that group runs from 2.7% to 14.1%.
- Is it safe
Interest coverage was 8.83x in FY2025, in the band labelled "Comfortable" (6.00x and above), on lines anchored on Damodaran's interest-coverage table, suggesting an interest bill operating profit covers many times over.
- Year by year against peers
- Whether Unilever PLC's return on invested capital stayed above the median of the Consumer Defensive sector, year by year. (FY2022 to FY2025, 4 fiscal years of Unilever PLC with a comparable figure)
- The direction
- Which way Unilever PLC's return on equity has moved, and how steadily. (FY2016 to FY2025, 10 filed years of Unilever PLC)
- What could explain it
- What in Unilever PLC's filed statements could explain the movements. (3 readings drawn from the statement lines Unilever PLC filed)
- What to check next
- What to check next on Unilever PLC, and where in its filings. (2 questions for Unilever PLC)
- In one paragraph
- One paragraph on Unilever PLC's returns, cash, balance sheet and price. (14 of sixteen figures read for Unilever PLC)
These are UL’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.
Research ULPart of Serious. New accounts start with 30 days of Professional, free, no card.
What changed
SEC filingCompany statement
The newest accounts on file are the FY2025 annual report: 20-F, filed Mar 12, 2026, accession 0000217410-26-000007.
Quality
The returns the business earns on its capital, and the margins behind them.
SEC filingComputed
| Figure | Value, source and document |
|---|---|
| Return on invested capital, after tax | 16.6% Computed. Sources for Return on invested capital, after taxFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Return on equity | 61.0% Computed. Sources for Return on equityFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Return on capital employed, pre-tax | 18.5% Computed. Sources for Return on capital employed, pre-taxFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Return on assets | 13.4% Computed. Sources for Return on assetsFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Gross margin | 47.0% Computed. Sources for Gross marginFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Operating margin | 17.9% Computed. Sources for Operating marginFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Net margin | 18.8% Computed. Sources for Net marginFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
UL 18.8%
5.1%18.8%
Financial strength
What it owes against what it owns, and whether it can meet what falls due.
SEC filingComputedCompany statement
| Figure | Value, source and document |
|---|---|
| Debt to equity | 1.76 Computed. Sources for Debt to equityFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Current ratio | 0.79 Computed. Sources for Current ratioFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Quick ratio | 0.60 Computed. Sources for Quick ratioFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Interest coverage | 8.83x Computed. Sources for Interest coverageFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
Altman Z-scoreWhy n/aWe do not hold this figure for this company, so there is nothing to show. | n/a Computed. Sources for Altman Z-score21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Net debt | 23.42B Computed. Sources for Net debtFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
The balance sheet, line by line
Financial health
What Unilever PLC owned and owed at the end of fiscal 2025, from the balance sheet it filed (20-F, filed Mar 12, 2026, 0000217410-26-000007).
| Total assets | 70.47B Filed. Sources for Total assetsFY2025 20-F, filed Mar 12, 2026 |
|---|---|
| Total liabilities | 52.88B Filed. Sources for Total liabilitiesFY2025 20-F, filed Mar 12, 2026 |
| Shareholders' equity | 15.53B Filed. Sources for Shareholders' equityFY2025 20-F, filed Mar 12, 2026 |
| Cash | 3.94B Filed. Sources for CashFY2025 20-F, filed Mar 12, 2026 |
| Total debt | 27.36B Filed. Sources for Total debtFY2025 20-F, filed Mar 12, 2026 |
| Net debt | 23.42B |
| Current ratio | 0.79 |
| Debt to equity | 1.76 |
Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.
Valuation context
Market dataSEC filingComputed
| Figure | Value, source and document |
|---|---|
| Price to earnings | 13.40x Computed. Sources for Price to earnings21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
P/E on trailing twelve monthsWhy n/aA trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 0 for this company. Nothing is drawn rather than a line built from fewer. | n/a Computed. Sources for P/E on trailing twelve monthsClose of Nov 11, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings |
| Price to book | 8.17x Computed. Sources for Price to book21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Price to sales | 2.51x Computed. Sources for Price to sales21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Enterprise value to EBIT | 16.63x Computed. Sources for Enterprise value to EBIT21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Enterprise value to EBITDA | 14.53x Computed. Sources for Enterprise value to EBITDAClose of Nov 11, 2026 · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Price to earnings over growth | 0.88 Computed. Sources for Price to earnings over growth21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
Diluted earnings per shareWhy n/aThe FY2025 filing carries no diluted earnings per share we could read. | n/a Filed. Sources for Diluted earnings per shareFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
Graham numberWhy n/aWe do not hold this figure for this company, so there is nothing to show. | n/a Computed. Sources for Graham numberFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
We publish no fair value or price target of our own. Value UL on your own assumptions in the DCF workbench, starting from the filed figures.
Its own record, and companies like it
Valuation
What the market charges for Unilever PLC today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.
| Share price | 65.78 USD |
|---|---|
| Market capitalisation | 141.70B USD |
| Enterprise value to EBITDA | 14.53x |
| Graham number | n/a |
| Diluted earnings per share | n/a |
Price to earnings on trailing twelve months: A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 0 for this company. Nothing is drawn rather than a line built from fewer.
Companies like Unilever PLC
- Kimberly-Clark Corporation (KMB)Market cap 36.20B USD
- Colgate-Palmolive Company (CL)Market cap 77.90B USD
- Church & Dwight Co., Inc. (CHD)Market cap 26.44B USD
- Somnigroup International Inc (SGI)Market cap 14.39B USD
- The Clorox Company (CLX)Market cap 12.92B USD
Same industry (Household & Personal Products) and size band (Large, 10B to 200B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.
Cash generation
SEC filingComputed
| Figure | Value, source and document |
|---|---|
| Free cash flow yield | 5.5% Computed. Sources for Free cash flow yield21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Free cash flow | 6.93B EUR Computed. Sources for Free cash flowFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Free cash flow margin | 13.7% Computed. Sources for Free cash flow marginFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
Dividend yieldWhy n/aWe do not hold this figure for this company, so there is nothing to show. | n/a Computed. Sources for Dividend yield21:00 UTC · FY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
Payout ratioWhy n/aWe do not hold this figure for this company, so there is nothing to show. | n/a Computed. Sources for Payout ratioFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
Filings
Every figure, the year it is for and the document it was read from.
SEC filingMarket data
The filed figures
Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.
| Figure | Value | Year | As of |
|---|---|---|---|
| 13.40x | FY2025 | Nov 11, 2026 | |
FormulaShare price / earnings per share. Where the filing states no earnings per share this listing can be priced on, which is every 20-F and 40-F filer because theirs is stated per ordinary share, it is market capitalisation / net income: the same multiple, undiluted. As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 8.17x | FY2025 | Nov 11, 2026 | |
FormulaMarket capitalisation / shareholders equity As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 16.63x | FY2025 | Nov 11, 2026 | |
Formula(Market capitalisation + total debt - cash) / operating income, or over the filing's own EBIT (income before tax + interest expense) where the filer tags no operating line, as Johnson & Johnson does not in any of its ten filed years. As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 5.5% | FY2025 | Nov 11, 2026 | |
FormulaFree cash flow per share / share price x 100 As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 16.6% | FY2025 | Mar 12, 2026 | |
FormulaVendor trailing-twelve-month return on invested capital where one is published, which uses after-tax operating profit over total assets less current liabilities. Otherwise our own recompute: NOPAT / (shareholders equity + total debt - cash) x 100, where NOPAT is the filed operating profit after tax, or the filing's own EBIT after tax where the filer tags no operating line. As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| n/a | FY2025 | Nov 11, 2026 | |
| n/a The filed cash flow statement reports no dividend paid at all. That is not the same as a filed zero, and we will not read it as one. | |||
FormulaCommon dividends paid in the latest filed year / market capitalisation x 100. n/a where the filing cannot support it: a special or first-year payment, a total that mixes preferred dividends, or a cash-flow statement over 15 months old. As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 1.76 | FY2025 | Mar 12, 2026 | |
FormulaTotal debt / shareholders equity As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 0.79 | FY2025 | Mar 12, 2026 | |
FormulaCurrent assets / current liabilities As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 2.51x | FY2025 | Nov 11, 2026 | |
FormulaMarket capitalisation / revenue As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 0.88 | FY2025 | Nov 11, 2026 | |
FormulaPrice to earnings / the annual earnings growth rate, in percentage points As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| n/a | FY2025 | Nov 11, 2026 | |
| n/a We hold no figure here and no stored reason for its absence. The gap is ours, not the company's. | |||
Formula1.2 x working capital/assets + 1.4 x retained earnings/assets + 3.3 x EBIT/assets + 0.6 x market value of equity/total liabilities + 1.0 x revenue/assets As ofThe close on Nov 11, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| -2.12 | FY2025 | Mar 12, 2026 | |
FormulaAn eight-variable index of year-on-year changes in receivables, gross margin, asset quality, revenue, depreciation, overheads, leverage and accruals As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 6/9 | FY2025 | Mar 12, 2026 | |
FormulaOne point each for: positive return on assets, positive operating cash flow, rising return on assets, operating cash flow above net income, falling leverage, rising current ratio, no new shares issued, rising gross margin, rising asset turnover. As ofThe filing date of the statements below, for FY2025. Form20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itIncome statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tabForm20-FFiledMar 12, 2026PeriodFY2025Accession0000217410-26-000007What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000217410-26-000007, leaves this page and opens in a new tab | |||
| 65.78 USD | n/a | Nov 11, 2026 | |
FormulaThe last close we hold, in the currency the listing trades in. As ofThe close on Nov 11, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| -3.8% | n/a | Nov 11, 2026 | |
Formula(price now - price a year ago) / price a year ago. It counts no dividend, so a high payer reads lower here than a holder's own return. As ofThe close on Nov 11, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
The figures are computed from the accounts for fiscal 2025, the newest full year on file. 11 filed fiscal years on record, FY2015 to FY2025, from SEC EDGAR. Prices as of Nov 11, 2026. Ratios recomputed Nov 11, 2026. Two facts, because a recompute is not a fresh quote.
The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.
Ten years of filed figures, year by year
Ten years of filed figures
10 filed fiscal years, FY2016 to FY2025, read from the annual reports Unilever PLC filed with the SEC. Each year names its filing. Amounts in EUR, as filed.
| Year | Revenue | Operating income | Net income | EPS, diluted | Free cash flow | Operating margin | Return on equity | Filing |
|---|---|---|---|---|---|---|---|---|
| FY2025 | 50.50B | 9.04B | 9.47B | n/a | 6.93B | 17.9% | 61.0% | 20-F, Mar 12, 20260000217410-26-000007 |
| FY2024 | 52.48B | 8.83B | 5.74B | n/a | 8.14B | 16.8% | 28.7% | 20-F, Mar 13, 20250000217410-25-000015 |
| FY2023 | 51.68B | 9.00B | 6.49B | n/a | 8.23B | 17.4% | 35.8% | 20-F, Mar 14, 20240000217410-24-000017 |
| FY2022 | 60.07B | 10.76B | 7.64B | n/a | 5.83B | 17.9% | 40.2% | 20-F, Mar 13, 20230000217410-23-000016 |
| FY2021 | 52.44B | 8.70B | 6.05B | n/a | 6.86B | 16.6% | 35.4% | 20-F, Mar 9, 20220000217410-22-000009 |
| FY2020 | 50.72B | 8.30B | 5.58B | n/a | 8.20B | 16.4% | 36.6% | 20-F, Mar 10, 20210001193125-21-075770 |
| FY2019 | 51.98B | 8.71B | 5.63B | n/a | 6.79B | 16.8% | 42.6% | 20-F, Mar 9, 20200001193125-20-067343 |
| FY2018 | 50.98B | 12.64B | 9.37B | n/a | 5.99B | 24.8% | 82.2% | 20-F, Mar 11, 20190001193125-19-070426 |
| FY2017 | 53.72B | 8.96B | 6.02B | n/a | 6.37B | 16.7% | 44.8% | 20-F/A, Mar 8, 20180001193125-18-074695 |
| FY2016 | 52.71B | 7.80B | 5.18B | n/a | 5.24B | 14.8% | 31.7% | 20-F/A, Mar 8, 20180001193125-18-074695 |
- Revenue, compound annual growth FY2016 to FY2025: -0.5%
- Earnings, compound annual growth FY2016 to FY2025: 6.9%
- Earnings per share: Fewer than two filed years carry earnings per share.
- Free cash flow, compound annual growth FY2016 to FY2025: 3.2%
Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.
Risks and guardrails
The accounting screens, the published tests, and the lines you can set to be told.
ComputedCompany statement
| Figure | Value, source and document |
|---|---|
| Beneish M-score | -2.12 Computed. Sources for Beneish M-scoreFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Piotroski F-score | 6/9 Computed. Sources for Piotroski F-scoreFY2025 20-F, filed Mar 12, 2026, 0000217410-26-000007 |
| Named tests met | 3 of 30 Computed. Sources for Named tests met |
| Beta | -0.03 Computed. Sources for Beta21:00 UTC |
The named tests
Of 30 tests value investors published: 3 met, 24 not met, 3 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.
Which tests, by name(all 30)
- Meets
- ROIC at or above WACC; High return on tangibles; Cash-flow yield and ROIC
- Does not
- Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; High yield, low payout; Low beta, profitable; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); High returns, low debt; Owner earnings yield; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
- Not measured
- Dividends and buybacks; P/E times P/B (Benjamin Graham); Cash-covered dividend. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(10)
- Positive Earnings Streak: The latest filed year has no per-share earnings we can read; the test needs 10.
- Altman Z-Score: We do not hold this figure for this company, so there is nothing to show.
- Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
- Dividend Yield: We do not hold this figure for this company, so there is nothing to show.
- Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
- Share Count Change Yoy: We do not hold this figure for this company, so there is nothing to show.
- Price To Graham: We do not hold this figure for this company, so there is nothing to show.
- Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.
- Dividend Streak: We do not hold this figure for this company, so there is nothing to show.
- Price Tangible Book: We do not hold this figure for this company, so there is nothing to show.
Declared positions
Whether anybody here owns this company.
Positions declared by Javier Sanz Alvarez: no holding in any company shown here, as of October 3, 2026.
A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.
What this cannot tell you
- 10 figures could not be read on this company, among them Positive Earnings Streak, Altman Z-Score, Eps Growth 5Y. Each blank in the table above names the rest, with its reason. 3 named tests come back incomplete because of them, which is neither met nor missed.
And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.
Then we check your line against newly filed data and write to you the night our data shows it broke. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published. It is Professional, the plan a new account starts on for 30 days, one trial per person.
No card. 30 free days, and nothing is charged unless you choose a plan.
ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.
Margin Notes
Once a week, what changed in the filings of US-listed companies, and what it can mean for a thesis.